Imagion Biosystems
- Short interest
- 0.01%
- 0.00 pp 30d
- as of 24 Dec 2024
- Reported shorts
- 12K
- Shares on issue
- 201.341M
Imagion Biosystems (IBX) Short Interest
Imagion Biosystems (ASX:IBX) had 0.01% of shares reported as short positions as of 24 Dec 2024, representing 11,970 shares. Imagion Biosystems operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Imagion Biosystems
Research and development of medical diagnostics
Company profile →Imagion Biosystems (ASX:IBX) has 0.01% of its shares on issue reported as short positions as of 24 Dec 2024, or about 11,970 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.42% in January 2019. IBX is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads IBX today
- Zanger BreakoutNot a candidate
- CAN SLIMNot a candidate
- Minervini Trend TemplateNot a candidate
- Crowded-Short BreakoutNot a candidate
- Quality compoundersNot a candidate
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
IBX fundamentals
In the half year to 30 Jun 2026, Imagion Biosystems (ASX:IBX) recorded a net loss after tax of A$2.0M. Net margin −13,313.1% (FY). Figures are in AUD, the company's reporting currency; source: Company filing (extracted), ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest IBX news
All news- Appendix 4C and Quarterly Activities Report - September 2026
asx · 7 Oct 2026
- StockTake: Imagion clears key hurdle for Phase 2 trial
stockhead · 30 Sept 2026
- IBX Secures Central Ethics Approval - Key Phase 2 Milestone
asx · 29 Sept 2026
Company details
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss IBX
Start a research thread or post the first pulse update